SDF-1 triggers G0Inc−CD34+ cells into G1 and makes them progress through S + G2/M phases in synergy with Tpo and SF
Cytokines . | % of PB Inc−CD34+ cells in cell cycle phases4-150 (mean ± SD) . | ||
---|---|---|---|
G0 . | G1 . | S + G2/M . | |
0 h culture time | 28.3 ± 5.8 | 69.4 ± 6.2 | 1.9 ± 0.9 |
48 h culture time | |||
SDF-1− | |||
No cytokine | 21.5 ± 5.1 | 72.2 ± 3.1 | 6.8 ± 1.4 |
SF | 25.3 ± 5.1 | 52.4 ± 2.5 | 20.1 ± 3.4‡ |
Tpo | 20.8 ± 4.2 | 67.4 ± 2.8 | 13.1 ± 3.24-151 |
Flt-3 ligand | 28.8 ± 4.8 | 63.8 ± 4.8 | 8.2 ± 3.5 |
SDF-1+ | |||
No cytokine | 6.4 ± 1.8‡ | 81.8 ± 4.1 | 11.2 ± 2.1 |
SF | 10.5 ± 3.24-151 | 66.3 ± 2.9 | 22.3 ± 2.44-153 |
Tpo | 8.4 ± 2.1‡ | 63.8 ± 3.1 | 24.1 ± 3.94-153 |
Flt-3 ligand | 9.1 ± 2.8 | 79.7 ± 3.5 | 12.4 ± 2.8 |
Cytokines . | % of PB Inc−CD34+ cells in cell cycle phases4-150 (mean ± SD) . | ||
---|---|---|---|
G0 . | G1 . | S + G2/M . | |
0 h culture time | 28.3 ± 5.8 | 69.4 ± 6.2 | 1.9 ± 0.9 |
48 h culture time | |||
SDF-1− | |||
No cytokine | 21.5 ± 5.1 | 72.2 ± 3.1 | 6.8 ± 1.4 |
SF | 25.3 ± 5.1 | 52.4 ± 2.5 | 20.1 ± 3.4‡ |
Tpo | 20.8 ± 4.2 | 67.4 ± 2.8 | 13.1 ± 3.24-151 |
Flt-3 ligand | 28.8 ± 4.8 | 63.8 ± 4.8 | 8.2 ± 3.5 |
SDF-1+ | |||
No cytokine | 6.4 ± 1.8‡ | 81.8 ± 4.1 | 11.2 ± 2.1 |
SF | 10.5 ± 3.24-151 | 66.3 ± 2.9 | 22.3 ± 2.44-153 |
Tpo | 8.4 ± 2.1‡ | 63.8 ± 3.1 | 24.1 ± 3.94-153 |
Flt-3 ligand | 9.1 ± 2.8 | 79.7 ± 3.5 | 12.4 ± 2.8 |
PB CD34+ cells purified immediately after density gradient separation (Inc−) were incubated (1 × 105 cells/mL) in a serum-free StemαA medium in presence or absence of Tpo (10 ng/mL), SF (50 ng/mL), Flt-3 ligand (50 ng/mL), SDF-1 (0.5 ng/mL) used alone, or in combination. At various time points, cells were harvested, counted, and dually stained with PI and anti-Ki67-FITC mAb before flow cytometry analysis.
Based on 3 independent experiments.
P < .003 and
P < .0001 versus no factor.
P < .003 versus SDF-1 alone.